Simon Quick Advisors, LLC Eli Lilly & CO Transaction History

Simon Quick Advisors, LLC

$1.57 Billion
Q3 2024

A detailed history of Simon Quick Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Simon Quick Advisors, LLC holds 4,781 shares of LLY stock, worth $3.57 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

4,781

Previous 4,106 16.44%

Holding current value

$3.57 Million

Previous $3.72 Million 13.94%

% of portfolio

0.27%

Previous 0.26%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$772.14 - $960.02 $521,194 - $648,013	675 Added 16.44%	4,781 $4.24 Million
Q2 2024 Aug 02, 2024	SELL	$724.87 - $909.04 $114,529 - $143,628	-158 Reduced 3.71%	4,106 $3.72 Million
Q1 2024 Apr 19, 2024	BUY	$592.2 - $792.28 $791,771 - $1.06 Million	1,337 Added 45.68%	4,264 $3.32 Million
Q4 2023 Jan 16, 2024	BUY	$525.19 - $619.13 $146,002 - $172,118	278 Added 10.49%	2,927 $1.71 Million
Q3 2023 Oct 24, 2023	BUY	$434.7 - $599.3 $336,892 - $464,457	775 Added 41.36%	2,649 $1.42 Million
Q2 2023 Aug 01, 2023	BUY	$350.74 - $468.98 $75,409 - $100,830	215 Added 12.96%	1,874 $878,000
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $250,678 - $294,409	807 Added 94.72%	1,659 $569,000
Q4 2022 Jan 30, 2023	BUY	$321.55 - $374.67 $273,960 - $319,218	852 New	852 $311,000
Q2 2022 Aug 08, 2022	SELL	$278.73 - $327.27 $98,391 - $115,526	-353 Closed	0 $0
Q1 2022 May 05, 2022	BUY	$234.69 - $291.66 $1,642 - $2,041	7 Added 2.02%	353 $101,000
Q4 2021 Feb 08, 2022	BUY	$224.85 - $279.04 $15,289 - $18,974	68 Added 24.46%	346 $96,000
Q3 2021 Oct 27, 2021	BUY	$221.6 - $272.71 $7,312 - $8,999	33 Added 13.47%	278 $64,000
Q2 2021 Jul 21, 2021	SELL	$180.55 - $233.54 $180 - $233	-1 Reduced 0.41%	245 $56,000
Q1 2021 May 06, 2021	SELL	$164.32 - $212.72 $49,131 - $63,603	-299 Reduced 54.86%	246 $45,000
Q4 2020 Jan 27, 2021	BUY	$130.46 - $172.63 $39,398 - $52,134	302 Added 124.28%	545 $92,000
Q3 2020 Oct 26, 2020	SELL	$146.22 - $169.13 $5,702 - $6,596	-39 Reduced 13.83%	243 $36,000
Q1 2020 Apr 09, 2020	SELL	$119.05 - $147.35 $6,666 - $8,251	-56 Reduced 16.57%	282 $39,000
Q4 2019 Jan 06, 2020	BUY	$106.92 - $132.43 $32,076 - $39,729	300 Added 789.47%	338 $44,000
Q3 2019 Oct 16, 2019	SELL	$106.79 - $116.16 $10,358 - $11,267	-97 Reduced 71.85%	38 $4,000
Q2 2019 Aug 05, 2019	BUY	$110.79 - $129.32 $14,956 - $17,458	135 New	135 $0
Q2 2018 Aug 10, 2018	SELL	$75.7 - $86.88 $4,314 - $4,952	-57 Closed	0 $0
Q1 2018 May 07, 2018	BUY	$74.21 - $87.6 $74 - $87	1 Added 1.79%	57 $4,000
Q4 2017 Feb 13, 2018	SELL	$81.94 - $87.89 $258,848 - $277,644	-3,159 Reduced 98.26%	56 $5,000
Q3 2017 Nov 06, 2017	SELL	$77.07 - $85.54 $77 - $85	-1 Reduced 0.03%	3,215 $275,000
Q2 2017 Aug 11, 2017	BUY	N/A	3,216	3,216 $265,000

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $709B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simon Quick Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simon Quick Advisors, LLC with notifications on news.

Account

Simon Quick Advisors, LLC Eli Lilly & CO Transaction History